Karnail S Atwal

This inventor holds 65 USPTO granted patents and 1 published patent application, plus 6 CIPO patents and 1 EPO patent, primarily in Heterocyclic Compounds (CPC class 5142). Top assignees: E. R. Squibb Sons, Inc., Bristol-Myers Squibb Compnay, Redpoint Bio Corporation. Active years: 1987-2010.

USPTO Granted Patents = 65 (Patent Applications = 1)

% Patents Active = 96.9

CIPO Patents = 6 (Patent Applications = 17)

EPO Patents = 1

Average Co-Inventor Count = 1.7

ph-index = 17

Forward Citations = 828(Granted Patents)

Forward Citations (Not Self Cited) = 756(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Cranbury, NJ (US) (1987 - 1993)
Newton, PA (US) (1995 - 1998)
Newtown, PA (US) (1991 - 2009)
Pennington, NJ (US) (2005 - 2010)

Company Filing History:

38 out of 1,624

E. R. Squibb Sons, Inc.

patents

26 out of 3,736

Bristol-Myers Squibb Compnay

patents

1 out of 8

Redpoint Bio Corporation

patents

Years Active: 1987-2010

Loading Chart...

Areas of Expertise:

Heterocyclic Compounds

Potassium Channel Inhibitors

Antiarrhythmic Agents

Dihydropyrimidine Derivatives

Lactam Derivatives

Benzopyran Derivatives

Chiral Cyclopropane

Enantiomers

Sulfonamido Compounds

Aryl Urea Derivatives

Phenylalanine Derivatives

Myocardial Cell Necrosis

65 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7674831 - Heterocyclic compounds as sweetener enhancers (2010-03-09),

2. 7541362 - Heterocyclic dihydropyrimidine compounds (2009-06-02),

3. 7326705 - Heterocyclic sodium/proton exchange inhibitors and method (2008-02-05),

4. 7157451 - Heterocyclic dihydropyrimidine compounds (2007-01-02),

5. 6916813 - (1-phenyl-2-heteoaryl)ethyl-guanidine compounds as inhibitors of mitochondrial F1F0 ATP hydrolase (2005-07-12),

6. 6887870 - Heterocyclic sodium/proton exchange inhibitors and method (2005-05-03),

7. 6881753 - Potassium channel inhibitors and method (2005-04-19),

8. 6784189 - Potassium channel inhibitors and method (2004-08-31),

9. 6706720 - Heterocyclic dihydropyrimidine compounds (2004-03-16),

10. 6664250 - Lactam derivatives as antiarrhythmic agents (2003-12-16),

11. 6624309 - Benzoic acid derivatives and related compounds as antiarrhythmic agents (2003-09-23),

12. 6511977 - Potassium channel inhibitors and method (2003-01-28),

13. 6472427 - Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile (2002-10-29),

14. 6458835 - Method of inhibiting or treating chemotherapy-induced hair loss (2002-10-01),

15. 6262122 - Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl)amino]methyl]amino]benzonitrile (2001-07-17),

Title: Karnail S Atwal - Pioneering Inventor from Newtown, PA

Introduction: Karnail S Atwal is a distinguished inventor based in Newtown, PA, known for his groundbreaking contributions to various fields through his innovative creations.

Latest Patents: Karnail S Atwal holds several patents in cutting-edge technologies related to renewable energy, sustainable agriculture, and advanced materials.

Career Highlights: With a career spanning over two decades, Karnail S Atwal has established himself as a visionary inventor with a keen focus on developing solutions that address pressing global challenges.

Collaborations: Throughout his career, Karnail S Atwal has collaborated with leading research institutions, universities, and companies to bring his inventions from concept to reality, showcasing his ability to work effectively in multidisciplinary teams.

Conclusion: Karnail S Atwal's relentless pursuit of innovation and his commitment to creating a positive impact on society make him a true trailblazer in the world of inventions.